-
Our company won the title of embryonic enterprise in Haidian District
2019/09/10 admin 30
-
Our company won the first place in the 2018 Zhongguancun Golden Seed Enterprise Roadshow - Daxing District Golden Seed Enterprise Group Competition
Attachment: List of the eighth batch of Zhongguancun Golden Seed Enterprises序號公司名稱1北京清核朝華科技有限公司2北京四方創(chuàng)能光電科技有限公司3北京龍德緣電力科技發(fā)展有限公司4北京博頓云聯(lián)技術(shù)有限公司5北京中科乾和環(huán)保科技服務(wù)有限公司6北京知行新能科技有限公司7北京賽則科技有限公司8北京暉豐能源科技有限公司9中航邁特粉冶
2019/06/10 admin 19
-
The "Zhongguancun Small and Micro Enterprise R&D Support" applied by our company was approved
2018/09/10 admin 25
-
News On Bispecific Antibodies
M802 bispecific antibody binds to a tumor target and an immune target simultaneously to recognize and link cancer cells and immune cells, subsequently forms an effective tumor-immune cell complex in c
2017/12/21 78
-
First CAR-T approved on market: Novartis Priced Kymriah $475,000
August 31, 2017, Novartis announced that the United States FDA has approved its CAR-T therapy Tisagenlecleucel (formerly known as CTL019) listed for the treatment of B cell precursor acute lymphoblast
2017/10/27 42
